Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
White Willow Bark wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.
any
Subcutaneous once-weekly injection (Ozempic / Wegovy)
120-240mg salicin daily (from standardized extract)
With meals, Divided doses
Standardized extract (15% salicin)
Weeks to months
Months (titrated over 16-20 weeks)
Months to years
Especially during dose escalation
1-2 weeks
1-4 weeks
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).
N Engl J Med (2021) · Rct · n=1961
Double-blind RCT in 1,961 adults with obesity/overweight WITHOUT diabetes, randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo plus lifestyle for 68 weeks
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT).
N Engl J Med (2023) · Rct · n=17604
Large cardiovascular-outcomes RCT: 17,604 patients with preexisting cardiovascular disease and overweight/obesity but WITHOUT diabetes
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6).
N Engl J Med (2016) · Rct · n=3297
Pre-approval cardiovascular-safety RCT in 3,297 patients with type 2 diabetes at high cardiovascular risk, semaglutide (0.5/1.0 mg/week) vs placebo for 104 weeks
Efficacy and Safety of White Willow Bark (Salix alba) Extracts
Phytotherapy research : PTR (2015) · Systematic review
In recent years, various in vitro and animal studies have demonstrated that the anti-inflammatory activity of willow bark extract is associated with down regulation of the inflammatory mediators tumor necrosis factor-α and nuclear factor-kappa B.
A systematic review on the effectiveness of willow bark for musculoskeletal pain
Phytotherapy research : PTR (2009) · Systematic review
All studies investigated ethanolic extracts with daily doses up to 240 mg salicin over periods of up to six weeks.
Cochrane review: Herbal therapy for low back pain
Cochrane Database of Systematic Reviews (2006) · Systematic review · n=500
Moderate evidence of efficacy
Based on Cochrane review showing dose-response relationship with 240mg more effective than 120mg. Studies limited to 6 weeks duration. Requires salicin-standardized extract.
AI-estimated from published studies. Interpret as directional guidance.
White Willow Bark has a higher evidence score (6/10 vs 8.5/10) and wins in 2 of 3 categories.
No known interactions between Semaglutide and White Willow Bark have been documented in our database. However, always consult a healthcare provider before combining supplements.